Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Stiller

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1988
Effects of immunosuppression with cyclosporine on beta cell function and clinical remission in very early overt type I diabetesJ Dupre, C R Stiller
Transplantation Proceedings|February 1, 1991
Should cyclosporine be continued indefinitely?C R Stiller, G Opelz
Canadian Family Physician Medecin De Famille Canadien|January 26, 2011
The immunocompromised patientJ L Mahon, C R Stiller
Transplantation Proceedings|September 1, 1978
Perspectives in patient monitoringC R Stiller, N R Sinclair
Advances in Internal Medicine|January 1, 1986
Control of rejection of transplanted organsP A Keown, C R Stiller
Canadian Journal of Surgery. Journal Canadien De Chirurgie|July 1, 1986
Microvascular surgery as an adjunctive tool in renal transplantationJ L Chin, C R Stiller
Hospital Practice (Office Ed.)|May 15, 1987
Cyclosporine: a double-edged swordP A Keown, C R Stiller
Transplantation Proceedings|June 1, 1990
Ethics, justice, and commerce in transplantationJ B Dossetor, C R Stiller
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 1, 1975
Pancreatic pseudocyst and polycythemia after renal transplantationD M Grace, C R Stiller
Kidney International. Supplement|March 1, 1988
Dialysis or transplant: an integrated approach to end-stage kidney disease managementP A Keown, C R Stiller
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Advances in Experimental Medicine and Biology|January 1, 1988
Effects of immunosuppression with cyclosporine on beta cell function and clinical remission in very early overt type I diabetesJ Dupre, C R Stiller
Transplantation Proceedings|February 1, 1991
Should cyclosporine be continued indefinitely?C R Stiller, G Opelz
Canadian Family Physician Medecin De Famille Canadien|January 26, 2011
The immunocompromised patientJ L Mahon, C R Stiller
Transplantation Proceedings|September 1, 1978
Perspectives in patient monitoringC R Stiller, N R Sinclair
Advances in Internal Medicine|January 1, 1986
Control of rejection of transplanted organsP A Keown, C R Stiller
Canadian Journal of Surgery. Journal Canadien De Chirurgie|July 1, 1986
Microvascular surgery as an adjunctive tool in renal transplantationJ L Chin, C R Stiller
Hospital Practice (Office Ed.)|May 15, 1987
Cyclosporine: a double-edged swordP A Keown, C R Stiller
Transplantation Proceedings|June 1, 1990
Ethics, justice, and commerce in transplantationJ B Dossetor, C R Stiller
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 1, 1975
Pancreatic pseudocyst and polycythemia after renal transplantationD M Grace, C R Stiller
Kidney International. Supplement|March 1, 1988
Dialysis or transplant: an integrated approach to end-stage kidney disease managementP A Keown, C R Stiller
Pageof 15